- Healthcare Professionals
- Research
- Clinical trials
- glora study
2024-07-30T00:00:00.000+10:00
Ongoing
GLORA study
GLORA study
Haematology
A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (GLORA Study)
A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (GLORA Study)
Trial overview
Disease
Haematology
Topic
Diagnostics
Sponsor
Ascentage Pharma
Description
A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (GLORA Study)
Study details
For detailed information on this trial, please click here
Trial status
Opening August 2024
Location
Milton Keynes
:::
Priniciple Investigator
